GlobeNewsWire · ORKA · October 26, 2026

Oruka Therapeutics Announces Positive Week 16 Results for ORKA-001 from the Ongoing EVERLAST-B Trial in Moderate-to-Severe Psoriasis

Get the app for more

Explore stock news, insights and company research.